These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 11712812)

  • 1. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
    Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
    Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus.
    Gerszten K; Faul C; Kounelis S; Huang Q; Kelley J; Jones MW
    Gynecol Oncol; 1998 Jan; 68(1):8-13. PubMed ID: 9454652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
    Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
    Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
    Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
    Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
    Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
    Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
    Clayton Smith D; Kenneth Macdonald O; Gaffney DK
    Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
    Le T
    Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features of surgical stage I uterine carcinosarcoma.
    Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
    Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
    Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.